Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin effects on diuresis and renal function in acute decompensated heart failure
2018-003692-35Phase 2Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Acute Heart Failure (AHF) comparing Empagliflozin plus loop diuretics with Placebo plus loop diuretics (2 arms). Primary endpoint: Total urine output over 5 days. Started Feb 2019; status: completed.
02
Drugs
empagliflozin
03
Conditions
heart failure (HF)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2018-003692-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003692-35.